Collection
Digital Features - Oncology
- Submission status
- Open
- Open for submission from
- 01 January 2018
- Submission deadline
- Ongoing
This collection contains all papers published in the journal with digital features associated with them, including video abstracts, graphical abstracts and plain language summaries. Articles from Oncology and Therapy, Targeted Oncology, and Advances in Therapy.
Articles (37 in this collection)
-
-
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast
Authors
- Peter C. Black
- Bernhard J. Eigl
- Content type: Commentary
- Open Access
- Published: 02 February 2024
- Advances in Therapy
- Pages: 915 - 927
-
A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants
Authors (first, second and last of 5)
- Hong Tang
- Francesca Civoli
- Barbara Finck
- Content type: Original Research
- Open Access
- Published: 05 January 2024
- Advances in Therapy
- Pages: 991 - 1009
-
Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion
Authors
- Sandip Patel
- Jyoti D. Patel
- Content type: Commentary
- Open Access
- Published: 06 October 2023
- Advances in Therapy
- Pages: 5579 - 5590
-
Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast
Authors
- Wade T. Iams
- Kartik Konduri
- Content type: Commentary
- Open Access
- Published: 01 October 2023
- Advances in Therapy
- Pages: 5567 - 5578
-
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast
Authors (first, second and last of 4)
- Brian Dong
- Rita Lusen
- Lisa Kline
- Content type: Commentary
- Open Access
- Published: 29 September 2023
- Oncology and Therapy
- Pages: 411 - 418
-
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists
Authors (first, second and last of 4)
- Stephen V. Liu
- Ivy B. Elkins
- Sarah B. Goldberg
- Content type: Commentary
- Open Access
- Published: 26 September 2023
- Oncology and Therapy
- Pages: 419 - 431
-
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
Authors
- Reva Basho
- Megan-Claire Chase
- Content type: Commentary
- Open Access
- Published: 14 September 2023
- Oncology and Therapy
- Pages: 433 - 443
-
Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants
Authors (first, second and last of 5)
- Hong Tang
- Francesca Civoli
- Barbara Finck
- Content type: Original Research
- Open Access
- Published: 14 September 2023
- Advances in Therapy
- Pages: 4889 - 4906
-
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis
Authors
- Geoffrey Liu
- Vincent K. Lam
- Content type: Commentary
- Open Access
- Published: 12 August 2023
- Advances in Therapy
- Pages: 4117 - 4126
-
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma
Authors (first, second and last of 4)
- Philipp Ivanyi
- Jonas Paul Wiegmann
- Viktor Grünwald
- Content type: Commentary
- Open Access
- Published: 12 July 2023
- Advances in Therapy
- Pages: 3610 - 3619
-
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
Authors (first, second and last of 4)
- Philipp Ivanyi
- Jonas Paul Wiegmann
- Viktor Grünwald
- Content type: Commentary
- Open Access
- Published: 12 July 2023
- Advances in Therapy
- Pages: 3620 - 3625
-
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Authors
- Ola Landgren
- Omar Nadeem
- Content type: Commentary
- Open Access
- Published: 16 June 2023
- Advances in Therapy
- Pages: 3291 - 3303
-
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast
Authors
- Alex Filicevas
- Thomas Powles
- Content type: Commentary
- Open Access
- Published: 06 June 2023
- Oncology and Therapy
- Pages: 277 - 289
-
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
Authors
- Moshe C. Ornstein
- Laura S. Wood
- Content type: Commentary
- Open Access
- Published: 26 May 2023
- Advances in Therapy
- Pages: 3599 - 3609
-
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast
Authors
- Adam Brufsky
- Christopher Gallagher
- Content type: Commentary
- Open Access
- Published: 06 May 2023
- Targeted Oncology
- Pages: 321 - 326
-
Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast
Authors (first, second and last of 4)
- Thomas John
- Margarita Majem
- Jonathan Goldman
- Content type: Commentary
- Open Access
- Published: 19 December 2022
- Targeted Oncology
- Pages: 1 - 8
-
PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Authors (first, second and last of 11)
- Dermot O’Toole
- Pamela L. Kunz
- Ally Prebtani
- Content type: Original Research
- Published: 11 December 2022
- Advances in Therapy
- Pages: 671 - 690
-
Educational and Emotional Needs of Patients with Myelodysplastic Syndromes: An AI Analysis of Multi-Country Social Media
Authors
- Pauline P. Frank
- Mabel X. E. Lu
- Emma C. Sasse
- Content type: Original Research
- Open Access
- Published: 22 September 2022
- Advances in Therapy
- Pages: 159 - 173
-
Outcomes for Recurrent Mantle Cell Lymphoma Post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database
Authors (first, second and last of 6)
- Shinya Rai
- Yoshinori Tanizawa
- Masaomi Tajimi
- Content type: Original Research
- Open Access
- Published: 19 August 2022
- Advances in Therapy
- Pages: 4792 - 4807
-
The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice
Authors (first, second and last of 4)
- Seppo Meri
- Donald Bunjes
- Sonata Jodele
- Content type: Review
- Open Access
- Published: 04 July 2022
- Advances in Therapy
- Pages: 3896 - 3915
-
Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
Authors (first, second and last of 4)
- Qing Huang
- Kathleen L. Deering
- Lori A. Leslie
- Content type: Original Research
- Open Access
- Published: 24 May 2022
- Advances in Therapy
- Pages: 3292 - 3307
-
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)
Authors (first, second and last of 13)
- Akito Hata
- Yoshimasa Shiraishi
- Tomohide Tamura
- Content type: Brief Report
- Open Access
- Published: 04 March 2022
- Oncology and Therapy
- Pages: 253 - 262
-
Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
Authors
- Alex Filicevas
- Thomas B. Powles
- Content type: Commentary
- Open Access
- Published: 03 March 2022
- Oncology and Therapy
- Pages: 1 - 11
-
Podcast on the Management of Adverse Events Associated with Lorlatinib
Authors
- Todd M. Bauer
- Erin M. Bertino
- Content type: Commentary
- Open Access
- Published: 11 February 2022
- Advances in Therapy
- Pages: 1447 - 1456
-
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
Authors
- Massimo Breccia
- Content type: Commentary
- Open Access
- Published: 31 January 2022
- Advances in Therapy
- Pages: 1101 - 1106
-
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
Authors (first, second and last of 12)
- Edurne Arriola
- MarÃa González-Cao
- Dolores Isla
- Content type: Original Research
- Open Access
- Published: 15 January 2022
- Oncology and Therapy
- Pages: 167 - 184
-
American Society of Clinical Oncology 2021 Podcast: HR+, HER2− Breast Cancer
Authors
- Kwok-Leung Cheung
- Content type: Commentary
- Open Access
- Published: 07 August 2021
- Oncology and Therapy
- Pages: 267 - 272
-
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
Authors (first, second and last of 5)
- Adam Brufsky
- Xianchen Liu
- Rachel M. Layman
- Content type: Original Research Article
- Open Access
- Published: 02 August 2021
- Targeted Oncology
- Pages: 601 - 611
-
Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study
Authors (first, second and last of 7)
- Adam Goldman
- David Bomze
- Elad Maor
- Content type: Original Research Article
- Published: 10 May 2021
- Targeted Oncology
- Pages: 471 - 483
-
Incidence and Risk Factors of Pneumonitis in Patients with Non-Small Cell Lung Cancer: An Observational Analysis of Real-World Data
Authors (first, second and last of 6)
- Jerzy E. Tyczynski
- Ravi Potluri
- Alexander Liede
- Content type: Original Research
- Open Access
- Published: 28 April 2021
- Oncology and Therapy
- Pages: 471 - 488
-
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison
Authors (first, second and last of 12)
- Jörg Trojan
- Patrick Mollon
- Marino Venerito
- Content type: Original Research
- Open Access
- Published: 06 April 2021
- Advances in Therapy
- Pages: 2472 - 2490
-
Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations
Authors
- Hans-Christian Kolberg
- Georgia Savva Demetriou
- Vladimir Hanes
- Content type: Practical Approach
- Open Access
- Published: 11 January 2021
- Oncology and Therapy
- Pages: 225 - 238
-
The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab
Authors
- Jerome Goldschmidt
- Vladimir Hanes
- Content type: Practical Approach
- Open Access
- Published: 17 December 2020
- Oncology and Therapy
- Pages: 213 - 223
-
Evaluation of Nurse Preferences Between the Lanreotide Autogel New Syringe and the Octreotide Long-Acting Release Syringe: An International Simulated-Use Study (PRESTO)
Authors (first, second and last of 5)
- Daphne Adelman
- Xuan-Mai Truong Thanh
- David Cella
- Content type: Original Research
- Open Access
- Published: 11 March 2020
- Advances in Therapy
- Pages: 1608 - 1619
-
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Authors (first, second and last of 13)
- Riccardo Giampieri
- Elena Maccaroni
- Rossana Berardi
- Content type: Case Report
- Open Access
- Published: 05 December 2019
- Oncology and Therapy
- Pages: 161 - 169
-
Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease
Authors
- Maximilian Hochmair
- Content type: Review Article
- Open Access
- Published: 27 April 2018
- Targeted Oncology
- Pages: 269 - 285